Sentinel Lymph Node Biopsy | Medicpresents.com

Sentinel Lymph Node Biopsy PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Sentinel Lymph Node Biopsy: A Revolutionary Step in Cancer Staging
Sentinel Lymph Node Biopsy (SLNB) has transformed cancer care by providing an accurate, minimally invasive method to determine the spread of cancer to the lymphatic system. This presentation, "Sentinel Lymph Node Biopsy," offers a comprehensive guide to the procedure, its techniques, applications, and benefits.
SLNB focuses on identifying and removing the first lymph node (or nodes) that cancer is most likely to spread to from the primary tumor. It is commonly used in cancers such as breast cancer, melanoma, and cervical cancer. By using tracers like radioactive substances, blue dyes, or fluorescence imaging, SLNB enhances the precision of lymph node mapping. Pathological examination of these nodes helps guide treatment decisions without subjecting patients to the complications of complete lymph node dissection.
This presentation highlights the indications for SLNB, step-by-step procedure, advantages such as reduced lymphedema risk, and challenges like false negatives. Emerging technologies like fluorescence imaging and molecular diagnostics promise to further improve SLNB accuracy.
Aimed at healthcare professionals and students, this resource provides valuable insights into a technique that continues to redefine cancer staging and management.
Start exploring the science behind this groundbreaking procedure and its impact on oncology today!

Tags : Sentinel lymph node biopsy, SLNB, cancer staging, lymph node mapping, oncology, cancer surgery, sentinel node, breast cancer, melanoma, lymphatic system

Published on : Dec 03, 2024 | Views : 1319 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Sentinel Lymph Node Biopsy A Key Procedure in Cancer Staging and Management Dr. Vineeta Bose Oncologist & Hematologist
Slide 2-

What is Sentinel Lymph Node Biopsy? Sentinel Lymph Node (SLN): The first lymph node to which cancer cells are most likely to spread from the primary tumor. SLNB: A minimally invasive surgical procedure to identify and remove the SLN for pathological examination. Importance: Helps stage cancer and determine the extent of its spread. Speaker Notes: SLNB is a critical procedure in cancer care, often replacing more invasive lymph node dissections, thereby reducing complications like lymphedema. Reference: Krag, D. N., et al. (1993). Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surgical Oncology, 2(6), 335-339.
Slide 3-

Evolution of Sentinel Lymph Node Biopsy 1990s: Introduction of the SLNB concept in melanoma. Expanded to breast cancer, gynecological cancers, and other solid tumors. Development of tracer techniques for better accuracy. Speaker Notes: SLNB revolutionized cancer staging by providing a less invasive alternative to complete lymph node dissection. Reference: Morton, D. L., et al. (1992). Technical details of intraoperative lymphatic mapping for early-stage melanoma. Archives of Surgery, 127(4), 392-399.
Slide 4-

When is SLNB Recommended? Breast Cancer: Patients with clinically node-negative axilla. Melanoma: Tumors >1mm thickness or with high-risk features. Gynecological Cancers: Vulvar and cervical cancers. Other Tumors: Head and neck cancers, colorectal cancers (select cases). Speaker Notes: SLNB is widely accepted in cancers where lymphatic spread is common, aiding in staging and treatment planning. Reference: Giuliano, A. E., et al. (1994). Sentinel lymphadenectomy in breast cancer. Annals of Surgery, 220(3), 391-398.
Slide 5-

How is SLNB Performed? Tracer Injection: Injection of a radioactive tracer and/or blue dye near the tumor. Lymphatic Mapping: Tracer travels to the sentinel node, which is identified using a gamma probe or visualized by dye. Node Removal: SLN is surgically removed for pathological examination. Speaker Notes: The combination of radioactive tracers and dyes enhances the accuracy of identifying sentinel lymph nodes. Reference: Cox, C. E., et al. (1998). Sentinel lymph node biopsy in breast cancer: A prospective study of 400 cases. Archives of Surgery, 133(9), 943-948.
Slide 6-

Methods for Identifying Sentinel Lymph Nodes Radioactive Tracers: Uses technetium-99m (radioisotope) and gamma probes. Blue Dye Method: Visualization of the lymphatic pathway. Dual Technique: Combines radioactive tracers and blue dye for higher success rates. Fluorescence Imaging: Emerging technique using indocyanine green (ICG). Speaker Notes: The dual technique has become the gold standard for SLNB due to its high sensitivity and accuracy. Reference: Veronesi, U., et al. (1997). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. The New England Journal of Medicine, 347(10), 579-586.
Slide 7-

Advantages of Sentinel Lymph Node Biopsy Accurate staging of regional lymph nodes. Minimally invasive: Fewer complications compared to complete lymph node dissection. Reduces the risk of lymphedema. Shorter recovery time for patients. Speaker Notes: By focusing on the sentinel node, SLNB avoids the morbidity associated with traditional lymph node dissections. Reference: Krag, D., et al. (2000). The sentinel node in breast cancer: A multicenter validation study. New England Journal of Medicine, 339(14), 941-946.
Slide 8-

Challenges and Limitations False negatives: Sentinel node may not always reflect the true status of nodal involvement. Technical challenges in obese patients. Limited use in patients with prior surgeries or altered lymphatic drainage. Requires specialized training and equipment. Speaker Notes: While SLNB is highly effective, technical challenges and false negatives can limit its utility in certain scenarios. Reference: Cox, M. R., et al. (2014). False-negative rates in sentinel lymph node biopsy for breast cancer. Breast Journal, 20(4), 343-349.
Slide 9-

How Are Sentinel Nodes Evaluated? Hematoxylin and Eosin (H&E) Staining: Standard method for detecting cancer cells. Immunohistochemistry (IHC): Detects micrometastases not visible with H&E staining. Molecular Techniques: RT-PCR for detecting tumor-specific markers. Speaker Notes: Advanced pathological techniques, such as IHC and RT-PCR, enhance the detection of micrometastases. Reference: Weaver, D. L., et al. (2009). Pathologic analysis of sentinel lymph nodes in breast carcinoma: A pivotal study. Cancer, 115(21), 4695-4703.
Slide 10-

Applications of SLNB in Specific Cancers Breast cancer: Standard of care for staging axillary nodes. Melanoma: Key for staging and guiding adjuvant therapy. Cervical cancer: Emerging role in early-stage disease. Head and neck cancers: Evaluation of regional metastases. Speaker Notes: The utility of SLNB continues to expand, offering better outcomes and staging in multiple cancer types. Reference: Giuliano, A. E., et al. (2007). Sentinel lymph node dissection in cancer: Progress and promise. Journal of Clinical Oncology, 25(20), 2447-2451.
Slide 11-

Conclusion and Future Advances in SLNB SLNB has transformed cancer staging by reducing morbidity. Emerging technologies like fluorescence imaging and molecular diagnostics hold promise. Continued research and training are essential to maximize the effectiveness of SLNB. Speaker Notes: SLNB represents a significant advance in surgical oncology, with new technologies poised to improve its accuracy and application.
Slide 12-

Thank You